Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
97 hedge funds and large institutions have $181M invested in Calithera Biosciences, Inc in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 41 reducing their positions, and 26 closing their positions.
422% more call options, than puts
Call options by funds: $193K | Put options by funds: $37K
12% less funds holding
Funds holding: 110 → 97 (-13)
37% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 41
37% less capital invested
Capital invested by funds: $287M → $181M (-$106M)
46% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.73M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.87M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$1.3M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.25M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$725K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$10.9M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$2.93M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$2.39M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.63M |
| 5 |
Millennium Management
New York
|
-$1.2M |
CALA Hedge Fund Activity: Q3 2020 in Review
97 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2020, worth a combined $181M — down 37% from $287M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of CALA and 14 opened new positions — a net loss of 12 holders — while 41 trimmed existing stakes and 26 added.
The largest buyer was Wellington Management Group, adding an estimated $6.73M. The largest seller was BVF Inc, cutting an estimated $10.9M.
- 97 institutional investors held Calithera Biosciences, Inc (CALA) as of Q3 2020, down from 110 in Q2 2020.
- Funds reported $181M of Calithera Biosciences, Inc stock for Q3 2020, down 37% quarter-over-quarter.
- 14 funds opened new Calithera Biosciences, Inc positions in Q3 2020 and 26 closed out, a net change of -12 holders.
- The largest Calithera Biosciences, Inc buyer in Q3 2020 was Wellington Management Group, an estimated $6.73M added.
- The largest Calithera Biosciences, Inc seller in Q3 2020 was BVF Inc, an estimated $10.9M sold.
Based on aggregated 13F filings for Q3 2020.